While the highly significant association between free soluble anti-rhIL-2 autoantibodies and T1D is remarkable, the functional capacity of these antibodies—at the monoclonal level—to neutralize or otherwise modulate IL-2 function remains to be assessed. The gene discussed is IL2; the disease is type 1 diabetes mellitus.